Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.3100
+0.0162 (5.51%)
Aug 13, 2025, 9:58 AM - Market open
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $14.59 million as of August 13, 2025. Its market cap has decreased by -77.36% in one year.
Market Cap
14.59M
Enterprise Value
11.73M
1-Year Change
-77.36%
Ranking
Category
Stock Price
$0.31
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $14.59M, a decrease of -77.90%. That is a compound annual growth rate of -50.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 13.83M | -47.99% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |